Novonesis (Novozymes) B (MEX:NSISN) Beneish M-Score: -2.87 (As of Jun. 25, 2026)


MEX:NSISN Novonesis (Novozymes) B MEX:NSISN
91 GF Score
Price MXN911.11
GF Value MXN979.45
! 3 Warning Signs
View Full Analysis

What is Novonesis (Novozymes) B Beneish M-Score?

Novonesis (Novozymes) B MEX:NSISN 91 Beneish M-Score is -2.87 as of Jun. 25, 2026. GuruFocus rates MEX:NSISN with a GF Score™ of 91/100 and a GF Value™ of MXN979.45. The stock has 3 warning signs investors should review. Among 1,529 Chemicals companies, Novonesis (Novozymes) B ranks better than 79.53% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.87 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Novonesis (Novozymes) B's Beneish M-Score or its related term are showing as below:

MEX:NSISN' s Beneish M-Score Range Over the Past 10 Years
Min: -3.1   Med: -2.58   Max: -1.15
Current: -2.87

During the past 13 years, the highest Beneish M-Score of Novonesis (Novozymes) B was -1.15. The lowest was -3.10. And the median was -2.58.


Novonesis (Novozymes) B Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Novonesis (Novozymes) B's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novonesis (Novozymes) B Beneish M-Score Chart

Novonesis (Novozymes) B Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.30 -2.43 -2.54 -1.15 -3.10

Novonesis (Novozymes) B Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -2.67 0.00 -3.10 -2.87

MEX:NSISN vs LIN, SHW, ECL: Beneish M-Score Comparison

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis (Novozymes) B Beneish M-Score vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Beneish M-Score falls into.


MEX:NSISN
91GF Score
Novonesis (Novozymes) B MEX:NSISN
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novonesis (Novozymes) B Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Novonesis (Novozymes) B for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9555+0.528 * 0.9292+0.404 * 1.0209+0.892 * 1.0292+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.1253+4.679 * -0.042744-0.327 * 1.5487
=-2.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Total Receivables was MXN19,090 Mil.
Revenue was 23334.105 + 21012.272 + 22928.097 + 22119.424 = MXN89,394 Mil.
Gross Profit was 13231.624 + 11781.716 + 11710.576 + 11825.259 = MXN48,549 Mil.
Total Current Assets was MXN42,647 Mil.
Total Assets was MXN344,462 Mil.
Property, Plant and Equipment(Net PPE) was MXN63,692 Mil.
Depreciation, Depletion and Amortization(DDA) was MXN0 Mil.
Selling, General, & Admin. Expense(SGA) was MXN20,096 Mil.
Total Current Liabilities was MXN25,483 Mil.
Long-Term Debt & Capital Lease Obligation was MXN60,940 Mil.
Net Income was 4150.648 + 2589.11 + 2971.244 + 2970.974 = MXN12,682 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = MXN0 Mil.
Cash Flow from Operations was 3483.542 + 6919.755 + 10050.555 + 6951.819 = MXN27,406 Mil.
Total Receivables was MXN19,412 Mil.
Revenue was 23833.25 + 21432.235 + 22299.647 + 19290.339 = MXN86,855 Mil.
Gross Profit was 13144.117 + 10807.839 + 11967.157 + 7913.732 = MXN43,833 Mil.
Total Current Assets was MXN43,037 Mil.
Total Assets was MXN333,024 Mil.
Property, Plant and Equipment(Net PPE) was MXN64,473 Mil.
Depreciation, Depletion and Amortization(DDA) was MXN0 Mil.
Selling, General, & Admin. Expense(SGA) was MXN17,351 Mil.
Total Current Liabilities was MXN25,881 Mil.
Long-Term Debt & Capital Lease Obligation was MXN28,069 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(19089.646 / 89393.898) / (19412.067 / 86855.471)
=0.213545 / 0.223498
=0.9555

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(43832.845 / 86855.471) / (48549.175 / 89393.898)
=0.504664 / 0.543093
=0.9292

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (42646.814 + 63691.913) / 344462.095) / (1 - (43037.418 + 64473.188) / 333024.109)
=0.69129 / 0.677169
=1.0209

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=89393.898 / 86855.471
=1.0292

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 64473.188)) / (0 / (0 + 63691.913))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(20095.793 / 89393.898) / (17351.139 / 86855.471)
=0.224801 / 0.19977
=1.1253

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((60940.102 + 25483.436) / 344462.095) / ((28068.65 + 25881.282) / 333024.109)
=0.250894 / 0.162
=1.5487

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(12681.976 - 0 - 27405.671) / 344462.095
=-0.042744

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Novonesis (Novozymes) B has a M-score of -2.92 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.87 mean?
Novonesis (Novozymes) B (MEX:NSISN) has a Beneish M-Score of -2.87 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Novonesis (Novozymes) B and its competitors. According to the industry distribution chart, Novonesis (Novozymes) B ranks #313 out of 1529 companies in the Chemicals industry, placing it in the top 20.5%.
Is Novonesis (Novozymes) B's Beneish M-Score too high?
Novonesis (Novozymes) B's current Beneish M-Score is -2.87. Based on the distribution chart, Novonesis (Novozymes) B ranks #313 out of 1529 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Novonesis (Novozymes) B has a GF Score™ of 91/100, reflecting its overall financial health beyond just this single metric.
How does Novonesis (Novozymes) B's Beneish M-Score compare to LIN and SHW?
According to the Chemicals industry distribution chart, Novonesis (Novozymes) B ranks #313 out of 1529 companies for Beneish M-Score. This places Novonesis (Novozymes) B in the top 21% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Chemicals company?
A good Beneish M-Score depends on the Chemicals industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Novonesis (Novozymes) B and its competitors. Novonesis (Novozymes) B's current Beneish M-Score is -2.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novonesis (Novozymes) B stock overvalued right now?
Novonesis (Novozymes) B (MEX:NSISN) has a current Beneish M-Score of -2.87. The stock's GF Value™ is MXN979.45, compared to a current price of MXN911.11 — trading 7% below its estimated fair value. The current Beneish M-Score is -2.87. Novonesis (Novozymes) B's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Novonesis (Novozymes) B (MEX:NSISN), the current Beneish M-Score is -2.87 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Novonesis (Novozymes) B (MEX:NSISN) Overvalued in 2026?

Based on GuruFocus' analysis, Novonesis (Novozymes) B stock appears to be undervalued. The current stock price of MXN911.11 is trading 7% below its estimated GF Value™ of MXN979.45.

Key valuation signals for MEX:NSISN:

  • Beneish M-Score: -2.87
  • GF Value™: MXN979.45 vs. price of MXN911.11 (7% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the MEX:NSISN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Novonesis (Novozymes) B Business Description

Address Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs more than 11,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.
91GF Score

Get the complete analysis for MEX:NSISN

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN911.11
Price
MXN979.45
GF Value